Loading...
XSTO
CRADb
Market cap120mUSD
Jul 10, Last price  
35.70SEK
1D
-1.38%
1Q
31.73%
Jan 2017
196.27%
IPO
86.91%
Name

C Rad AB

Chart & Performance

D1W1MN
XSTO:CRADb chart
P/E
109.20
P/S
2.59
EPS
0.33
Div Yield, %
Shrs. gr., 5y
0.34%
Rev. gr., 5y
14.80%
Revenues
442m
-5.78%
1,291,1244,898,74914,234,44614,909,75525,775,90545,036,18453,191,61366,160,75182,653,556133,125,000190,110,000205,394,000221,628,000261,152,000301,326,000424,615,000469,004,000441,900,000
Net income
11m
-81.40%
-10,722,785-10,250,579-9,838,118-42,606,182-19,388,657-20,994,730-6,298,477-21,183,842-31,209,176-10,907,00021,191,000-13,800,00014,365,00025,102,0007,479,00035,529,00056,448,00010,500,000
CFO
71m
+136.40%
-10,055,732-8,726,049-5,014,115-20,426,509-13,063,389-22,856,329-16,611,834-22,951,019-44,623,107-4,020,000-9,606,00015,827,00018,447,00018,168,0009,690,00033,383,00030,076,00071,100,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports proton therapy from simulation to treatment; Catalyst+ HD Ring Gantry solution for patient positioning, real-time motion monitoring, and respiratory gating; and Sentinel 4DCT, a laser-based optical surface scanning system. It also provides Catalyst, a 4D surface guided radiation therapy (SGRT) solution; Catalyst HD, a SGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst PT, a tracking solution for particle therapy; and visual coaching solutions used for prospective and retrospective radiotherapy. In addition, the company offers cAutoVerify, an automation solution for the imaging suite and treatment room, automating patient identity validation, and accessory tracking; and cAccessory, which automates the registration and validation of treatment accessories. Further, it provides SmartPhantom RT, a device that allows automatic adjustment and alignment of fixed lasers with motorization; StaticPhantom, a set-up used to visually verify the precision of the alignment of lasers; high impact technology motorized system, a laser positioning system; HIT Single Diode; and HIT1, HIT3, and HIT5 patient positioning laser, as well as laser positioning products and solutions. Additionally, the company offers support and training services; and service contracts. C-Rad AB (publ) was incorporated in 2004 and is headquartered in Uppsala, Sweden.
IPO date
Jul 23, 2007
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT